These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11683531)

  • 21. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts.
    Jilka RL; O'Brien CA; Ali AA; Roberson PK; Weinstein RS; Manolagas SC
    Bone; 2009 Feb; 44(2):275-86. PubMed ID: 19010455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia.
    Shen V; Dempster DW; Mellish RW; Birchman R; Horbert W; Lindsay R
    Calcif Tissue Int; 1992 Mar; 50(3):214-20. PubMed ID: 1617495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
    Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
    J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
    Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
    J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium.
    Lindsay R; Zhou H; Cosman F; Nieves J; Dempster DW; Hodsman AB
    J Bone Miner Res; 2007 Apr; 22(4):495-502. PubMed ID: 17227219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats.
    Prakasam G; Yeh JK; Chen MM; Castro-Magana M; Liang CT; Aloia JF
    Bone; 1999 May; 24(5):491-7. PubMed ID: 10321909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment.
    Sato M; Ma YL; Hock JM; Westmore MS; Vahle J; Villanueva A; Turner CH
    J Pharmacol Exp Ther; 2002 Jul; 302(1):304-13. PubMed ID: 12065731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor-alpha dependency of estrogen's stimulatory action on cancellous bone formation in male mice.
    McDougall KE; Perry MJ; Gibson RL; Colley SM; Korach KS; Tobias JH
    Endocrinology; 2003 May; 144(5):1994-9. PubMed ID: 12697707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RAGE supports parathyroid hormone-induced gains in femoral trabecular bone.
    Philip BK; Childress PJ; Robling AG; Heller A; Nawroth PP; Bierhaus A; Bidwell JP
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E714-25. PubMed ID: 20028966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.
    Choudhary S; Canalis E; Estus T; Adams D; Pilbeam C
    PLoS One; 2015; 10(3):e0120164. PubMed ID: 25781979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
    Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
    Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
    Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
    Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE
    Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat.
    Mitlak BH; Burdette-Miller P; Schoenfeld D; Neer RM
    J Bone Miner Res; 1996 Apr; 11(4):430-9. PubMed ID: 8992873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y; Won YY; Baek MH; Lim SK
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphiregulin lacks an essential role for the bone anabolic action of parathyroid hormone.
    Jay FF; Vaidya M; Porada SM; Andrukhova O; Schneider MR; Erben RG
    Mol Cell Endocrinol; 2015 Dec; 417():158-65. PubMed ID: 26427650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.